Profile

Ron Baik

Associate

GordonMD® Global Investments LP

Ron Baik is an Associate at GordonMD Global Investments LP. Prior to joining, Ron was a PhD student and an Experimental Immuno-Oncology (EIO) Scholar at Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, where he developed novel tools to engineer mitochondrial DNA and studied how mitochondrial mutations affect cancer development. He brings over 10 years of academic research experience, including work at Stanford University, the Innovative Genomics Institute at UC Berkeley, and Northwestern University. His research spans epigenetics, stem cell biology, genome engineering, metabolism, cancer, and computational biology, with contributions to publications across basic and translational science. During his doctoral training, he participated in Cornell University’s Life Sciences Technology Innovation Fellowship and founded a biotechnology startup.

Ron earned his Bachelor of Science in Biomedical Science from Andrews University and his PhD in Molecular Biology from Weill Cornell Medicine.

BACKGROUND

Ron Baik is an Associate at GordonMD Global Investments LP. Prior to joining, Ron was a PhD student and an Experimental Immuno-Oncology (EIO) Scholar at Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, where he developed novel tools to engineer mitochondrial DNA and studied how mitochondrial mutations affect cancer development. He brings over 10 years of academic research experience, including work at Stanford University, the Innovative Genomics Institute at UC Berkeley, and Northwestern University. His research spans epigenetics, stem cell biology, genome engineering, metabolism, cancer, and computational biology, with contributions to publications across basic and translational science. During his doctoral training, he participated in Cornell University’s Life Sciences Technology Innovation Fellowship and founded a biotechnology startup.

Ron earned his Bachelor of Science in Biomedical Science from Andrews University and his PhD in Molecular Biology from Weill Cornell Medicine.